Axe Compute Sells Helomics AI Cancer Diagnostics Business to DataMEDS AI in All-Stock Transaction

September 18, 2026

Axe Compute has sold its wholly owned Helomics Corporation (AI cancer diagnostics) business to DataMEDS AI in an all-stock transaction. The deal exchanges Helomics for DataMEDS shares, letting Axe Compute retain economic exposure to Helomics’ future development through its stake in DataMEDS.

Buyers
DataMEDS AI
Targets
Helomics Corporation
Sellers
Axe Compute
Location
Pennsylvania, United States
Transaction Type
Divestiture

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.